Covid-19 Fear and Compliance With Protective Measures of Students

October 14, 2022 updated by: Hacer Gok Ugur, T.C. ORDU ÜNİVERSİTESİ

Covid-19 Fear and Compliance With Protective Measures of Students Continuing Face-to-Face Education in the Covid-19 Pandemic Process

This study was carried out to determine the fear of Covid-19 and the compliance with protective measures of students who continue their education face-to-face during the covid-19 pandemic process.

Study Overview

Status

Completed

Conditions

Detailed Description

The study was carried out descriptively. The study population of a province pandemic period junior ongoing training to face in Turkey. Sample constituted reached 188 students with snowball sampling method. The data of the study were collected using the "Questionnaire Form" prepared by the researchers and the "Covid-19 Fear Scale". Data collection tools were applied to the participants electronically via Google Forms.

Study Type

Observational

Enrollment (Actual)

188

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Ordu Province
      • Ordu, Ordu Province, Turkey, 5200
        • Ordu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

continued face-to-face education students

Description

Inclusion Criteria:

Students who volunteered to participate in the study, had their parents' consent, had a web-based smart device, and continued face-to-face education were included.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Covid-19 Fear
Time Frame: November-March
Covid-19 Fear Scale: The scale developed by Ahorsu et al. (2020) was adapted to Turkish by Bakioglu, Korkmaz and Ercan (2020). The scale, consisting of seven questions, is a 5-point Likert (1: Strongly disagree, 5: Strongly agree) type. The scale consists of one dimension. The scores that can be obtained from the scale range from 7 to 35. The total score obtained from all items of the scale reflects the level of Covid-19 fear experienced by the individual. A high score means experiencing a high level of fear.
November-March

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Information Form
Time Frame: November-March
The form consists of two parts. In the first part, there are 14 questions that determine the socio-demographic characteristics of the students (age, gender, class, family type, mother education, father education, monthly income level, knowledge about Covid-19, information source, catching Covid-19, family's catching Covid-19, worrying about the family in terms of the illness, thinking that they can be protected from Covid-19 and being knowledgeable about the methods of protection from Covid-19). In the second part, the practices of students on protection methods from Covid-19 were prepared within the framework of mask (14 questions), hand washing (8 questions) and social distance (17 questions) measures. No scoring will be made in this section. Students' compliance with protective measures will be evaluated as "yes" "no" "sometimes".
November-March

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

T.C. ORDU ÜNİVERSİTESİ

Investigators

  • Principal Investigator: Hacer GOK UGUR, Assoc. Prof., T.C. ORDU ÜNİVERSİTESİ

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 12, 2020

Primary Completion (ACTUAL)

March 30, 2021

Study Completion (ACTUAL)

May 1, 2021

Study Registration Dates

First Submitted

March 22, 2021

First Submitted That Met QC Criteria

April 15, 2021

First Posted (ACTUAL)

April 19, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 17, 2022

Last Update Submitted That Met QC Criteria

October 14, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • q9wrjg2p

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid-19

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe